Article

Compliance likely an issue when amblyopia therapy fails

When treating a child with amblyopia, what steps do you take when the Pediatric Eye Disease Investigator Group (PEDIG) guidelines do not work? The first thing to consider is whether you're getting poor compliance with your therapy, said Lionel Kowal, MD, FRACOphth, FRACS, Ophthalmology Eye and Ear Hospital, Melbourne, Australia.

When treating a child with amblyopia, what steps do you take when the Pediatric Eye Disease Investigator Group (PEDIG)guidelines do not work? The first thing to consider is whether you're getting poor compliance with therapy, said LionelKowal, MD, FRACOphth, FRACS, Ophthalmology Eye and Ear Hospital, Melbourne, Australia.

With patching, for example, Dr. Kowal said documentation in parent-kept diaries tends to overestimate the actual patchingtime. That could explain why in some studies, 2 hours of patching yields the same therapeutic results as 6 hours.

"Parents don't like parading an obviously defective child," Dr. Kowal said. "They also don't like to be 'mean' to theirchildren. So it's a tough situation for everyone involved.

"Sometimes we find that the best way to get your therapy to work is to find a way to help parents maintain enthusiasm for thetask," he said.

Other measures to consider if you are following the PEDIG guidelines but are not achieving satisfactory results, according toDr. Kowal:

  • If you're already patching, try atropine.
  • If you're using atropine, try patching.
  • Look for missed organic factors.
  • Correct the patient's strabismus.
  • In severe cases, consider refractive surgery.

Finally, remember the parents. "You must find a way to keep the therapeutic environment alive," Dr. Kowal said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.